July 2025
1. LIU C, Tang Y, Wang J, Zhou Y, et al
   Effect of Polygonatum Sibiricum polysaccharides on nude mice model of prostate cancer PC?3 cells.
   Oncol Rep. 2025;54:84.
   

   >> Share

   
   April 2025
2. GUO X, Li S
   Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis and targeted therapy (Review).
   Oncol Rep. 2025;53:46.
   

   >> Share

   
   February 2025
3. YANG C, Wang L, Gong C, Lv D, et al
   Antibody?drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review).
   Oncol Rep. 2025;53:21.
   

   >> Share

   
   November 2024
4. ZHOU Y, Ji Z, Yan W, Zhou Z, et al
   [Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
   Oncol Rep. 2024;52:152.
   

   >> Share

   
   October 2024
5. NOURUZI S, Johnson F, Kumar S, Sivak O, et al
   Targeting adenocarcinoma and enzalutamide?resistant prostate cancer using the novel anti?androgen inhibitor ADA?308.
   Oncol Rep. 2024;52:132.
   

   >> Share

   
   June 2024
6. LIU Y, Qin Z, Yang K, Liu R, et al
   [Corrigendum] Cripto?1 promotes epithelial?mesenchymal transition in prostate cancer via Wnt/beta?catenin signaling.
   Oncol Rep. 2024;51:75.
   

   >> Share

   
   
7. PAN J, Tong F, Ren N, Ren L, et al
   Role of N(6)?methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review).
   Oncol Rep. 2024;51:88.
   

   >> Share

   
   May 2024
8. HSIA YJ, Lin ZM, Zhang T, Chou TC, et al
   Butyrate increases methylglyoxal production through regulation of the JAK2/Stat3/Nrf2/Glo1 pathway in castration?resistant prostate cancer cells.
   Oncol Rep. 2024;51:71.
   

   >> Share

   
   March 2024
9. PARAJULI KR, Jung Y, Taichman RS
   Abscisic acid signaling through LANCL2 and PPARgamma induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells.
   Oncol Rep. 2024;51:39.
   

   >> Share

   
   January 2024
10. LEE DY, Chun JN, So I, Jeon JH, et al
    Oncogenic role of FOXM1 in human prostate cancer (Review).
    Oncol Rep. 2024;51:15.
    

    >> Share

    
    December 2023
11. LEE DY, Lee S, Kim YS, Park S, et al
    Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK?dependent manner.
    Oncol Rep. 2023;50:218.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share